US PRESIDENT Donald Trump has released details of a number of policy reforms aiming to lower medication prices in the USA, but analysts have criticised the measures as "failing to lay a glove on Big Pharma".
Measures proposed include capping out-of-pocket drug costs for patients enrolled in the US Medicare scheme, and forcing insurers to pass rebates onto their patients - however notable omissions from the policy include any statement which would allow importation of cheaper medication from Canada and other countries.
During his election campaign Trump accused drug companies of "getting away with murder" when it came to medication pricing.
The above article was sent to subscribers in Pharmacy Daily's issue from 14 Feb 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 14 Feb 18
